Role of Calcium-independent Phospholipase A2 in Cortex Striatum Thalamus Cortex Circuitry-enzyme Inhibition Causes Vacuous Chewing Movements in Rats

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2007 Sep 5

PMID 17768607

Citations 5

Authors

Li-Yen Lee

Wei-Yi Ong

Akhlaq A Farooqui

Jean-Marc Burgunder

Affiliations

Soon will be listed here.

Abstract

Rationale: High levels of calcium independent phospholipase A2 (iPLA2) are present in certain regions of the brain, including the cerebral cortex, striatum, and cerebellum (Ong et al. 2005).

Objectives: The present study was carried out to elucidate a possible role of the enzyme in the motor system.

Methods: The selective iPLA2 inhibitor bromoenol lactone (BEL), the nonselective PLA2 inhibitor methyl arachidonyl fluorophosphonate (MAFP), and an antisense oligonucleotide were used to interfere with iPLA2 activity in various components of the motor system. Control animals received injections of carrier (phosphate buffered saline, PBS) at the same locations. The number of vacuous chewing movements (VCM) was counted from 1 to 14 days after injection.

Results: Rats that received BEL and high-dose MAFP injections in the striatum, thalamus, and motor cortex, but not the cerebellum, showed significant increase in VCM, compared to those injected with PBS at these locations. BEL-induced VCM were blocked by intramuscular injections of the anticholinergic drug, benztropine. Increased VCM was also observed after intrastriatal injection of antisense oligonucleotide to iPLA2. The latter caused a decrease in striatal iPLA2 levels, confirming a role of decreased enzyme activity in the appearance of VCM.

Conclusions: These results suggest an important role for iPLA2 in the cortex-striatum-thalamus-cortex circuitry. It is postulated that VCM induced by iPLA2 inhibition may be a model of human parkinsonian tremor.

Citing Articles

Effect of PLA2G6 and SMPD1 Variants on the Lipid Metabolism in the Cerebrospinal Fluid of Patients with Parkinson's Disease: A Non-targeted Lipidomics Study.

Li Y, Ji G, Lian M, Liu X, Xu Y, Gui Y Neurol Ther. 2023; 12(6):2021-2040.

PMID: 37707705 PMC: 10630267. DOI: 10.1007/s40120-023-00542-0.

iPLA2β knockout mouse, a genetic model for progressive human motor disorders, develops age-related neuropathology.

Blanchard H, Taha A, Cheon Y, Kim H, Turk J, Rapoport S Neurochem Res. 2014; 39(8):1522-32.

PMID: 24919816 PMC: 4364003. DOI: 10.1007/s11064-014-1342-y.

Maintenance of synaptic stability requires calcium-independent phospholipase A₂ activity.

Allyson J, Bi X, Baudry M, Massicotte G Neural Plast. 2012; 2012:569149.

PMID: 22685677 PMC: 3364014. DOI: 10.1155/2012/569149.

Role of calcium independent phospholipase A2 in maintaining mitochondrial membrane potential and preventing excessive exocytosis in PC12 cells.

Ma M, Yeo J, Farooqui A, Ong W Neurochem Res. 2010; 36(2):347-54.

PMID: 21116712 DOI: 10.1007/s11064-010-0340-y.

Nanomolar vitamin E alpha-tocotrienol inhibits glutamate-induced activation of phospholipase A2 and causes neuroprotection.

Khanna S, Parinandi N, Kotha S, Roy S, Rink C, Bibus D J Neurochem. 2009; 112(5):1249-60.

PMID: 20028458 PMC: 2821814. DOI: 10.1111/j.1471-4159.2009.06550.x.

References

Egan M, Hurd Y, Ferguson J, Bachus S, Hamid E, Hyde T . Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol. Psychopharmacology (Berl). 1996; 127(4):337-45. DOI: 10.1007/s002130050095. View

Andreassen O, Ferrante R, Aamo T, Beal M, Jorgensen H . Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience. 2003; 122(3):717-25. DOI: 10.1016/j.neuroscience.2003.08.058. View

Brown W, Chambers K, Doody A . Phospholipase A2 (PLA2) enzymes in membrane trafficking: mediators of membrane shape and function. Traffic. 2003; 4(4):214-21. DOI: 10.1034/j.1600-0854.2003.00078.x. View

Katzenschlager R, Sampaio C, Costa J, Lees A . Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev. 2003; (2):CD003735. PMC: 8728160. DOI: 10.1002/14651858.CD003735. View

Salamone J, Mayorga A, Trevitt J, Cousins M, Conlan A, Nawab A . Tremulous jaw movements in rats: a model of parkinsonian tremor. Prog Neurobiol. 1999; 56(6):591-611. DOI: 10.1016/s0301-0082(98)00053-7. View

Salamone J, Lalies M, Channell S, Iversen S . Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat. Psychopharmacology (Berl). 1986; 88(4):467-71. DOI: 10.1007/BF00178508. View

Strokin M, Sergeeva M, Reiser G . Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br J Pharmacol. 2003; 139(5):1014-22. PMC: 1573920. DOI: 10.1038/sj.bjp.0705326. View

Fujita S, Ikegaya Y, Nishikawa M, Nishiyama N, Matsuki N . Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A(2) inhibitor in rat hippocampal slices. Br J Pharmacol. 2001; 132(7):1417-22. PMC: 1572704. DOI: 10.1038/sj.bjp.0703970. View

Farooqui A, Antony P, Ong W, Horrocks L, Freysz L . Retinoic acid-mediated phospholipase A2 signaling in the nucleus. Brain Res Brain Res Rev. 2004; 45(3):179-95. DOI: 10.1016/j.brainresrev.2004.03.002. View

10.

Lees A . Alternatives to levodopa in the initial treatment of early Parkinson's disease. Drugs Aging. 2005; 22(9):731-40. DOI: 10.2165/00002512-200522090-00002. View

11.

Steinpreis R, Salamone J . Effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats. Pharmacol Biochem Behav. 1993; 46(2):405-9. DOI: 10.1016/0091-3057(93)90371-y. View

12.

Gattaz W, Kollisch M, Thuren T, Virtanen J, Kinnunen P . Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy. Biol Psychiatry. 1987; 22(4):421-6. DOI: 10.1016/0006-3223(87)90164-8. View

13.

Yang H, Mosior M, Ni B, Dennis E . Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2 from rat brain. J Neurochem. 1999; 73(3):1278-87. DOI: 10.1046/j.1471-4159.1999.0731278.x. View

14.

Gattaz W, Hubner C, Nevalainen T, Thuren T, Kinnunen P . Increased serum phospholipase A2 activity in schizophrenia: a replication study. Biol Psychiatry. 1990; 28(6):495-501. View

15.

Ellison G, Johansson P, Levin E, See R, Gunne L . Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats. Psychopharmacology (Berl). 1988; 96(2):253-7. DOI: 10.1007/BF00177570. View

16.

Strokin M, Chechneva O, Reymann K, Reiser G . Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2. Neuroscience. 2006; 140(2):547-53. DOI: 10.1016/j.neuroscience.2006.02.026. View

17.

Wolf M, Izumi Y, Zorumski C, Gross R . Long-term potentiation requires activation of calcium-independent phospholipase A2. FEBS Lett. 1995; 377(3):358-62. DOI: 10.1016/0014-5793(95)01371-7. View

18.

Balsinde J, Balboa M, Dennis E . Antisense inhibition of group VI Ca2+-independent phospholipase A2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages. J Biol Chem. 1997; 272(46):29317-21. DOI: 10.1074/jbc.272.46.29317. View

19.

Menard C, Valastro B, Martel M, Chartier E, Marineau A, Baudry M . AMPA receptor phosphorylation is selectively regulated by constitutive phospholipase A(2) and 5-lipoxygenase activities. Hippocampus. 2005; 15(3):370-80. DOI: 10.1002/hipo.20061. View

20.

Antony P, Freysz L, Horrocks L, Farooqui A . Effect of retinoic acid on the Ca2+-independent phospholipase A2 in nuclei of LA-N-1 neuroblastoma cells. Neurochem Res. 2001; 26(1):83-8. DOI: 10.1023/a:1007636801035. View